NickFi

SRPT - good potential

Long
NASDAQ:SRPT   Sarepta Therapeutics, Inc.
SRPT has insider purchasing stock and many of the top analysts are recommending a buy.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.